Preferential expression of NY-BR-1 and GATA-3 in male breast cancer.

Giovanni Battista BiserniEnrico Di OtoLinda Eszter MoskovszkyMaria Pia FoschiniZsuzsanna Varga

Published in: Journal of cancer research and clinical oncology (2017)

We found a high sensitivity for all the markers analyzed. Moreover, the expression of NY-BR-1 and GATA-3 seemed the most effective for labelling male breast cancer in primary and metastatic setting.

Keyphrases

poor prognosis
transcription factor
squamous cell carcinoma
binding protein
long non coding rna